Literature DB >> 29050382

Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.

Michael Schöll1,2, Rik Ossenkoppele3, Olof Strandberg1, Sebastian Palmqvist1,4, Jonas Jögi5, Tomas Ohlsson6, Ruben Smith1,4, Oskar Hansson1,7.   

Abstract

Patients with Alzheimer's disease can present with different clinical phenotypes. Individuals with late-onset Alzheimer's disease (>65 years) typically present with medial temporal lobe neurodegeneration and predominantly amnestic symptomatology, while patients with early-onset Alzheimer's disease (<65 years) exhibit greater neocortical involvement associated with a clinical presentation including dyspraxia, executive dysfunction, or visuospatial impairment. We recruited 20 patients with early-onset Alzheimer's disease, 21 with late-onset Alzheimer's disease, three with prodromal early-onset Alzheimer's disease and 13 with prodromal late-onset Alzheimer's disease, as well as 30 cognitively healthy elderly controls, that had undergone 18F-AV-1451 tau positron emission tomography and structural magnetic resonance imaging to explore whether early- and late-onset Alzheimer's disease exhibit differential regional tau pathology and atrophy patterns. Strong associations of lower age at symptom onset with higher 18F-AV-1451 uptake were observed in several neocortical regions, while higher age did not yield positive associations in neither patient group. Comparing patients with early-onset Alzheimer's disease with controls resulted in significantly higher 18F-AV-1451 retention throughout the neocortex, while comparing healthy controls with late-onset Alzheimer's disease patients yielded a distinct pattern of higher 18F-AV-1451 retention, predominantly confined to temporal lobe regions. When compared against each other, the early-onset Alzheimer's disease group exhibited greater uptake than the late-onset group in prefrontal and premotor, as well as in inferior parietal cortex. These preliminary findings indicate that age may constitute an important contributor to Alzheimer's disease heterogeneity highlighting the potential of tau positron emission tomography to capture phenotypic variation across patients with Alzheimer's disease.
© The Author (2017). Published by Oxford University Press on behalf of the Guarantors of Brain.

Entities:  

Keywords:  Alzheimer’s disease; age-at-onset; atrophy; positron emission tomography; tau

Mesh:

Substances:

Year:  2017        PMID: 29050382     DOI: 10.1093/brain/awx171

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  69 in total

1.  Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology.

Authors:  Ruben Smith; Moa Wibom; Daria Pawlik; Elisabet Englund; Oskar Hansson
Journal:  JAMA Neurol       Date:  2019-03-01       Impact factor: 18.302

2.  Imaging of tau deposits in adults with Niemann-Pick type C disease: a case-control study.

Authors:  Victor L Villemagne; D Velakoulis; V Doré; S Bozinoski; C L Masters; C C Rowe; Mark Walterfang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-28       Impact factor: 9.236

Review 3.  Imaging the evolution and pathophysiology of Alzheimer disease.

Authors:  William Jagust
Journal:  Nat Rev Neurosci       Date:  2018-11       Impact factor: 34.870

4.  The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease.

Authors:  Jennifer L Whitwell; Peter Martin; Jonathan Graff-Radford; Mary M Machulda; Matthew L Senjem; Christopher G Schwarz; Stephen D Weigand; Anthony J Spychalla; Daniel A Drubach; Clifford R Jack; Val J Lowe; Keith A Josephs
Journal:  Alzheimers Dement       Date:  2019-03-08       Impact factor: 21.566

5.  Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes.

Authors:  Marina Buciuc; Alexandra M Wennberg; Stephen D Weigand; Melissa E Murray; Matthew L Senjem; Anthony J Spychalla; Bradley F Boeve; David S Knopman; Clifford R Jack; Kejal Kantarci; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Jennifer L Whitwell; Keith A Josephs
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

6.  Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.

Authors:  Irene Sintini; Jonathan Graff-Radford; Matthew L Senjem; Christopher G Schwarz; Mary M Machulda; Peter R Martin; David T Jones; Bradley F Boeve; David S Knopman; Kejal Kantarci; Ronald C Petersen; Clifford R Jack; Val J Lowe; Keith A Josephs; Jennifer L Whitwell
Journal:  Brain       Date:  2020-07-01       Impact factor: 13.501

7.  Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.

Authors:  Brian A Gordon; Tyler M Blazey; Jon Christensen; Aylin Dincer; Shaney Flores; Sarah Keefe; Charles Chen; Yi Su; Eric M McDade; Guoqiao Wang; Yan Li; Jason Hassenstab; Andrew Aschenbrenner; Russ Hornbeck; Clifford R Jack; Beau M Ances; Sarah B Berman; Jared R Brosch; Douglas Galasko; Serge Gauthier; James J Lah; Mario Masellis; Christopher H van Dyck; Mark A Mintun; Gregory Klein; Smiljana Ristic; Nigel J Cairns; Daniel S Marcus; Chengjie Xiong; David M Holtzman; Marcus E Raichle; John C Morris; Randall J Bateman; Tammie L S Benzinger
Journal:  Brain       Date:  2019-04-01       Impact factor: 13.501

8.  Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.

Authors:  Rik Ossenkoppele; Gil D Rabinovici; Ruben Smith; Hanna Cho; Michael Schöll; Olof Strandberg; Sebastian Palmqvist; Niklas Mattsson; Shorena Janelidze; Alexander Santillo; Tomas Ohlsson; Jonas Jögi; Richard Tsai; Renaud La Joie; Joel Kramer; Adam L Boxer; Maria L Gorno-Tempini; Bruce L Miller; Jae Y Choi; Young H Ryu; Chul H Lyoo; Oskar Hansson
Journal:  JAMA       Date:  2018-09-18       Impact factor: 56.272

Review 9.  Early-onset Alzheimer Disease and Its Variants.

Authors:  Mario F Mendez
Journal:  Continuum (Minneap Minn)       Date:  2019-02

Review 10.  Disentangling Heterogeneity in Alzheimer's Disease and Related Dementias Using Data-Driven Methods.

Authors:  Mohamad Habes; Michel J Grothe; Birkan Tunc; Corey McMillan; David A Wolk; Christos Davatzikos
Journal:  Biol Psychiatry       Date:  2020-01-31       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.